
Jubilant Pharmova Share Price
₹966.95 -24.1 (-2.43%)
22 Feb, 2025 21:49
Start SIP in
JUBLPHARMA
Performance
- Low
- ₹961
- High
- ₹1,012
- 52 Week Low
- ₹538
- 52 Week High
- ₹1,310
- Open Price₹980
- Previous Close₹991
- Volume142,704
Investment Returns
- Over 1 Month + 2.45%
- Over 3 Month -14.46%
- Over 6 Month + 7.62%
- Over 1 Year + 65.72%
Smart Investing Starts Here Start SIP with Jubilant Pharmova for Steady Growth!
Jubilant Pharmova Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 24.6
- PEG Ratio
- 0
- Market Cap Cr
- 15,402
- P/B Ratio
- 2.6
- Average True Range
- 56.66
- EPS
- 21.16
- Dividend Yield
- 0.5
- MACD Signal
- -6.27
- RSI
- 46.96
- MFI
- 71.55
Jubilant Pharmova Financials
Jubilant Pharmova Technicals
EMA & SMA
Current Price
₹966.95
-24.1
(-2.43%)

-
- Bearish Moving Average 13
-
- Bullish Moving Average 3
- 20 Day
- ₹982.04
- 50 Day
- ₹1,008.83
- 100 Day
- ₹1,019.52
- 200 Day
- ₹948.61
Resistance and Support
979.83
- R3 1,049.07
- R2 1,030.28
- R1 998.62
- S1 948.17
- S2 929.38
- S3 897.72
Jubilant Pharmova Corporate Actions - Bonus, Splits, Dividends
Jubilant Pharmova F&O
About Jubilant Pharmova
- NSE Symbol
- JUBLPHARMA
- BSE Symbol
- 530019
- Managing Director
- Mr. Priyavrat Bhartia
- ISIN
- INE700A01033
Similar Stocks to Jubilant Pharmova
Jubilant Pharmova FAQs
Jubilant Pharmova share price is ₹966 As on 22 February, 2025 | 21:35
The Market Cap of Jubilant Pharmova is ₹15401.7 Cr As on 22 February, 2025 | 21:35
The P/E ratio of Jubilant Pharmova is 24.6 As on 22 February, 2025 | 21:35
The PB ratio of Jubilant Pharmova is 2.6 As on 22 February, 2025 | 21:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.